In Pharma Sustainability, AstraZeneca, Johnson & Johnson Rate High
On a scale of 1 to 100, AstraZeneca and Johnson & Johnson are the only pharmaceutical companies to rate above 70 in a recent survey of sustainability practices in the sector.
Other firms scoring highly are Baxter (66) and GlaxoSmithKline, Pfizer and Schering-Plough, all three of which scored 60.
Climate Counts evaluates firms’ commitments in four areas:
- whether they have measured their carbon footprint
- if they reduced their impact on global warming
- if they have supported or blocked climate legislation or policy
- to what level they have publicly disclosed their climate actions
AstraZeneca scored highly in all sectors except for policy, in which it scored a zero out of ten.
Johnson & Johnson scored highly in all sectors except for measuring its own carbon footprint, an area in which it scored 12 out of 22.
Stay Up-to-Date On Environmental Management, Energy & Sustainability News with EL's Free Daily Newsletter
Energy Manager News
- Singapore Commercial Building Energy Use Slows
- Enterprise, Alabama, Gradually Upgrading School Energy
- Meter Analytics Firm Aquicore Gets Seed Money
- The NHL Gets an Assist on Arena LED Deployment
- Energy Storage Sector Booming
- 2015 Solar Gen Is 31 Times Higher Than 2005
- Aspen Now 100% Powered by Renewable Resources
- Energy Efficiency: Building Owners Increasingly “Get It”